Premium listings
  • 3rd International Conference on Transcriptomics

    3rd International Conference on Transcriptomics

    Life Sciences Bangkok (Bangkok) March 13, 2017 Check with publisher

    Conference Series has been instrumental in conducting international Biochemistry meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Philadelphia, Orlando ...

  • Developing drugs for the treatment of neurodegenerative diseases

    Developing drugs for the treatment of neurodegenerative diseases

    PhD Studentships Liverpool December 3, 2016 Check with publisher

    Ageing is arguably the major biomedical challenge of the 21st century with the incidence of age-related diseases, and neurodegenerative diseases in particular, expected to increase dramatically in the coming decades. In model organisms, the process o...

  • Characterization and functional analysis of a novel cancer-associated gene

    Characterization and functional analysis of a novel cancer-associated gene

    PhD Studentships Liverpool May 15, 2016 Check with publisher

    Genes involved in common biological processes and diseases tend to be co-expressed. Therefore, genes co-expressed with known disease-associated genes will help identify new candidates for further studies. Our lab has recently developed a co-expressio...

  • Festival of Genomics London

    Festival of Genomics London

    Medical Sciences London (London) July 6, 2016 Check with publisher

    It's the return of the Festival. Last January 832 people gathered at the ExCeL London. There they found a room full of colleagues, new and old, all with the same mission: using genomics to improve healthcare. There was music, bubbles filled with DNA,...

  • Expertise in genomics and transcriptomics

    Expertise in genomics and transcriptomics

    Data Analysis - Analytics August 24, 2015 Check with publisher

    I lead the Integrative Genomics of Ageing Group (http://pcwww.liv.ac.uk/~aging/), and I have extensive experience in data analysis and integration of multidimensional data. Although my lab’s research integrates different strategies, its focal point i...

  • DrugAge database of compounds that increase lifespan

    DrugAge database of compounds that increase lifespan

    Biomedical Sciences Liverpool August 24, 2015 Check with publisher

    We're starting a new database of drugs and compounds (including natural products) with anti-ageing properties that extend longevity in model organisms. The database will be called DrugAge, and although we have some data already, we are looking for da...

Listings
  • Anti-TPBG ( E380C)-Mc-MMAD ADC

    Anti-TPBG ( E380C)-Mc-MMAD ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (E380C) conjugated via a Mc linker to MMAD. The MMAD is targeted to certain cancers by immunerecognition and delivered into can...

  • Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via an AcBut linker to calicheamicin. The calicheamicin is targeted to TPBG-positive cancers by immunerec...

  • Anti-TPBG (clone A3)-VC-MMAE ADC

    Anti-TPBG (clone A3)-VC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A3) conjugated via a VC linker to MMAE. The MMAE is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A3)-Mc-MMAF ADC

    Anti-TPBG (clone A3)-Mc-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A3) conjugated via a Mc linker to MMAF. The MMAF is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-SMCC-DMA ADC

    Anti-TPBG (clone A1)-SMCC-DMA ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    http://science-marketplace.org/services/drug-development_1/anti-tpbg-clone-a1-smcc-dma-adc_i3004 This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a SMCC linker to DMA. The DMA is targeted to TPBG-positive ca...

  • Anti-TPBG (clone A1)-Mc-MMAD ADC

    Anti-TPBG (clone A1)-Mc-MMAD ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a Mc linker to MMAD. The MMAD is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-VC-MMAD ADC

    Anti-TPBG (clone A1)-VC-MMAD ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAD. The MMAD is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-VC-MMAE ADC

    Anti-TPBG (clone A1)-VC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAE. The MMAE is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-Mc-MMAF ADC

    Anti-TPBG (clone A1)-Mc-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a Mc linker to MMAF. The MMAF is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TNFRSF8 (cAC10)-Mc-VC-PABC-MMAE ADC

    Anti-TNFRSF8 (cAC10)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10 ) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and deli...

  • Anti-TNFRSF8 (Brentuximab)-VC-PABC-MMAE ADC

    Anti-TNFRSF8 (Brentuximab)-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody conjugated via a VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into c...

  • Anti-TNFRSF8 (cAC10)-VC-MMAE ADC

    Anti-TNFRSF8 (cAC10)-VC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10)conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into...